PRORADIUM: Prospective analysis of the impact of germline mutations in homologous recombination (HR) genes on the response to radium-223 for metastatic castration resistant prostate cancer (mCRPC)
Por:
Castro, E, Mejorada, R, Medina, A, Giorgi, U, Laorden, N, Conteduca, V, De Velasco, G, Alameda, D, Sanz, A, Puente, J, del Alba, A, Borrega, P, Guzman, J, Fernandez-Parra, E, Rodriguez-Vida, A, Chirivella, I, Vazquez, F, Barrera, R, Lorente, D and Olmos, D
Publicada:
1 sep 2021
Ahead of Print:
1 sep 2021
Resumen:
Filiaciones:
Castro, E:
Spanish Natl Canc Res Ctr, Prostate Canc Res Unit, Madrid, Spain
Mejorada, R:
Spanish Natl Canc Res Ctr, Prostate Canc Res Unit, Madrid, Spain
Medina, A:
Ctr Oncol Coruna, Med Oncol, La Coruna, Spain
Giorgi, U:
IRCCS, Ist Romagnolo Studio Tumori, Dept Med Oncol, Meldola, Italy
Laorden, N:
Hosp Univ Princesa, Dept Oncol, Madrid, Spain
Conteduca, V:
IRCCS, Ist Romagnolo Studio Tumori, Dept Med Oncol, Meldola, Italy
De Velasco, G:
Univ Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain
Alameda, D:
Biomed Res Inst Malaga IBIMA, Genitourinary Oncol Traslat Res Grp, Malaga, Spain
Sanz, A:
Spanish Natl Canc Res Ctr, Prostate Canc Res Unit, Madrid, Spain
Puente, J:
Hosp Clin San Carlos, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Dept Med Oncol, CIBERONC, Madrid, Spain
del Alba, A:
Hosp Univ Puerta Hierro Majadahonda, Dept Med Oncol, Madrid, Spain
Borrega, P:
Hosp San Pedro Alcantara, Dept Med Oncol, Caceres, Spain
Guzman, J:
Hosp Gen Univ Ciudad Real, Dept Med Oncol, Ciudad Real, Spain
Fernandez-Parra, E:
Hosp Virgen Valme, Dept Med Oncol, Seville, Spain
Rodriguez-Vida, A:
Hosp Mar, Dept Med Oncol, Barcelona, Spain
Chirivella, I:
INCLIVA Biomed Res Inst, Dept Med Oncol, Valencia, Spain
:
Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain
Barrera, R:
Vall Hebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
Lorente, D:
Consorci Hosp Prov Castellon, Dept Med Oncol, Castellon de La Plana, Spain
Olmos, D:
Spanish Natl Canc Res Ctr, Prostate Canc Res Unit, Madrid, Spain
Bronze
|